This week, we will discuss SODaBIC trial: with ICU acidosis driven by multiple overlapping mechanisms, is bicarbonate infusion supported by robust evidence, or does it persist mainly out of habit rather than physiology?
On the right TRACK? Rivaroxaban to prevent cardiovascular events in advanced CKD.
NephJC Short: The Push Trial
NephJC Shorts: ALCHEMIST trial and Meta-analysis
In ESRD is spironolactone an overACHIEVEr?
The ACHIEVE visual abstract
Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?
Check out this crisp VA by Dr Akshaya Jayachandran.
NephJC Shorts: The end of the Fluid Wars?
NephJC Shorts: BedMed and Chronotherapy
Are E-Nudges Enough to Push Guideline-Based CKD Therapy?
Dialysis dreams and sleepless realities: the SLEEP-HD trial
Is Eculizumab a good Complement in STEC-HUS?
Optimizing “Sparse” Treatments for FSGS
Unlocking the door to living kidney donor paradise?
This week, nephrologists hope they found the key to no-dialysis-land, where kindness and detailed, multistep interventions make the path to kidney transplant much easier. This was foreseen in our Freely Filtered episode and disputed during #KidneyWK 2023 late-breaking clinical trials session. Still, when it comes to RCTs’ results, will it be Deja Vu or a happy ending?
